Minocycline-induced lupus - A systematic review

被引:66
作者
Schlienger, RG [1 ]
Bircher, AJ
Meier, CR
机构
[1] Univ Basel Hosp, Div Clin Pharmacol, Basel Pharmacoepidemiol Unit, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Div Dermatol, CH-4031 Basel, Switzerland
[3] Univ Basel, Dept Pharm, Inst Pharmacotherapy, CH-4003 Basel, Switzerland
[4] Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA USA
关键词
minocycline; auto-immune diseases; drug-induced lupus;
D O I
10.1159/000018387
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Minocycline has increasingly been associated with different adverse auto-immune reactions including drug-induced lupus, Objective: To identify the scope of minocycline-induced lupus and to characterise its typical features. Methods: Comprehensive Medline and Embase search of the English and non-English literature for case reports of minocyctine-induced lupus. Results: We included 57 cases of minocycline-induced lupus (mean age +/- SD at onset: 21.6 +/- 8.6 years, median time of exposure: 19 months, range 3 days to 6 years). All patients showed the clinical features of polyarthralgia/ polyarthritis often accompanied by liver abnormalities. Twelve patients had evidence of dermatological manifestations (i.e rash, livedo reticularis, oral ulceration, subcutaneous nodules, alopecia). The ANA test was positive in all patients. Conclusion: Long-term exposure to minocycline may be associated with drug-induced lupus. Baseline and periodic liver function and ANA tests accompanied by appropriate clinical monitoring are suggested for patients receiving long-term minocycline therapy. Copyright (C) 2000 S. Karger AG,Basel.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 54 条
[11]   TETRACYCLINE PROVOCATION IN LUPUS ERYTHEMATOSUS [J].
DOMZ, CA ;
MCNAMARA, DH ;
HOLZAPFEL, HF .
ANNALS OF INTERNAL MEDICINE, 1959, 50 (05) :1217-1226
[12]   SKIN PIGMENTATION DUE TO MINOCYCLINE TREATMENT OF FACIAL DERMATOSES [J].
DWYER, CM ;
CUDDIHY, AM ;
KERR, REI ;
CHAPMAN, RS ;
ALLAM, BF .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (02) :158-162
[13]   ANTIBIOTIC-RESISTANT PROPIONIBACTERIA IN ACNE - NEED FOR POLICIES TO MODIFY ANTIBIOTIC USAGE [J].
EADY, EA ;
JONES, CE ;
TIPPER, JL ;
COVE, JH ;
CUNLIFFE, WJ ;
LAYTON, AM .
BRITISH MEDICAL JOURNAL, 1993, 306 (6877) :555-556
[14]   Minocycline-induced autoimmune syndromes: An overview [J].
Elkayam, O ;
Yaron, M ;
Caspi, D .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1999, 28 (06) :392-397
[15]   Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena [J].
Elkayam, O ;
Levartovsky, D ;
Brautbar, C ;
Yaron, M ;
Burke, M ;
Vardinon, N ;
Caspi, D .
AMERICAN JOURNAL OF MEDICINE, 1998, 105 (06) :484-487
[16]   Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA [J].
Elkayam, O ;
Yaron, M ;
Caspi, D .
ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (10) :769-771
[17]   Minocycline-induced lupus [J].
Farver, DK .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (10) :1160-1163
[18]  
GENDI NST, 1995, BRIT J RHEUMATOL, V34, P584
[19]  
Golstein PE, 1997, AM J GASTROENTEROL, V92, P143
[20]   MINOCYCLINE-ASSOCIATED LUPUS-ERYTHEMATOSUS [J].
GORDON, PM ;
WHITE, MI ;
HERRIOT, R ;
MARTIN, JC ;
REID, DM .
BRITISH JOURNAL OF DERMATOLOGY, 1995, 132 (01) :120-121